Novel methods for targeting cancer stem cells

Details for Australian Patent Application No. 2011227023 (hide)

Owner Boston Biomedical, Inc.

Inventors Li, Chiang Jia; Leggett, David; Li, Youzhi; Li, Wei

Agent Cullens

Pub. Number AU-A-2011227023

PCT Pub. Number WO2011/116399

Priority 61/325,814 19.04.10 US; 61/315,890 19.03.10 US; 61/315,886 19.03.10 US

Filing date 21 March 2011

Wipo publication date 22 September 2011

International Classifications

A01N 43/16 Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/35 - having six-membered rings with one oxygen as the only ring hetero atom

Event Publications

27 September 2012 PCT application entered the National Phase

  PCT publication WO2011/116399 Priority application(s): WO2011/116399

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011227024-Enhanced GPS location in mobile asset tracking

2011227022-Novel compounds and compositions for targeting cancer stem cells